Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:21

Aloisio Souza Silva

Written by
Sunday, 08 August 2021 11:21

Riad Naim Younes

Written by
Sunday, 08 August 2021 11:21

Mingfang Zhao

Written by
Pro. Mingfang Zhao, MD, is currently the director of Second Ward of Medical Oncology, The First Hospital of China Medical University. She mainly engaged in the precise diagnosis and treatment and clinical translational research of a variety of solid tumors, especially good at the diagnosis and treatment of lung cancer and translational research. She has served as PI for several multi-center Phase III clinical trials and participated as the important contributor for many regional clinical trials as well. Dr. Mingfang Zhao has authored or co-authored in multiple medical articles on lung cancer and other malignancies. She is now the member of Lung cancer Group of the Oncology Branch of Chinese Medical Association; member of Chinese Society of Clinical Oncology (CSCO) Non-small Lung Cancer Professional Committee; director of Guangdong Clinical Trial Association (CTONG); member of the Lung Cancer Professional Committee and Member of the Internal Medicine Group of China Anti-cancer Association.
Sunday, 08 August 2021 11:21

Roselle De Guzman

Written by
Dr. Roselle De Guzman is a medical oncologist and associate professor at the Manila Central University-FDTMF Hospital in Manila, Philippines. She is currently chair of the American Society of Clinical Oncology (ASCO) Asia Pacific Regional Council and member of the Annual Meeting Scientific Program Committee. She is an academic clinician with special interest in lung cancer and global oncology.

Dr. de Guzman has served on ASCO committees and working groups. She was chair of the Multidisciplinary Cancer Management Course, the International Development and Education Award (IDEA) Working Group, and was a member of the steering committee of ASCO International Affairs. She has participated in the ASCO Leadership Development Program and served on advisory panels including Resource Stratified Practice Guideline Advisory Group, COVID-19 Clinical Questions Advisory group, and Educational Book Expert Panel. She is an invited peer reviewer for international journals including BMJ, JAMA Oncology, JCO Global Oncology and The Lancet Regional Health.
Sunday, 08 August 2021 11:21

Deebya Raj Mishra

Written by
Sunday, 08 August 2021 11:21

Adnan Abdul Jabbar

Written by
Dr. Adnan A. Jabbar is a medical oncologist serving as the Section Head and Associate Professor in the Department of Oncology at the AKUH. He did his MBBS from Dow Medical College and PhD from RUSH University, Chicago, Illinois, following which he completed his residency in Internal Medicine from Nassau University Medical Center, New York. He received his Hematology and Medical Oncology fellowship training from Winship Cancer Institute Emory School of Medicine, Atlanta, Georgia. He is American Board certified in Internal Medicine and Medical Oncology. In addition to his clinical commitments Dr. Jabbar serves as Director of Oncology Research Committee (DRC) and represents the department on various other committees in AKU.
Page 12 of 371